Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy

被引:0
|
作者
Nitta, Yohei [1 ]
Osaka, Jiro [1 ,2 ]
Maki, Ryuto [2 ]
Hakeda-Suzuki, Satoko [2 ,3 ]
Suzuki, Emiko [4 ,5 ]
Ueki, Satoshi [6 ]
Suzuki, Takashi [2 ]
Sugie, Atsushi [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
[2] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Japan
[3] Yokohama Natl Univ, Res Initiat & Promot Org, Yokohama, Japan
[4] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Japan
[5] Natl Inst Genet, Dept Gene Funct & Phenom, Mishima, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan
来源
ELIFE | 2024年 / 12卷
基金
日本学术振兴会;
关键词
dominant optic atrophy; Drosophila; OPA1; axonal degeneration; DYNAMIN-RELATED PROTEIN; SCLEROSIS-LIKE DISORDER; MITOCHONDRIAL-DNA; MUTATIONS; DISEASE; REPLICATION; FUSION; GENES; MOUSE; PATHOGENICITY;
D O I
10.7554/eLife.87880
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Autosomal dominant optic atrophy (DOA) is a progressive form of blindness caused by degeneration of retinal ganglion cells and their axons, mainly caused by mutations in the OPA1 mitochondrial dynamin like GTPase (OPA1) gene. OPA1 encodes a dynamin-like GTPase present in the mitochondrial inner membrane. When associated with OPA1 mutations, DOA can present not only ocular symptoms but also multi-organ symptoms (DOA plus). DOA plus often results from point mutations in the GTPase domain, which are assumed to have dominant-negative effects. However, the presence of mutations in the GTPase domain does not always result in DOA plus. Therefore, an experimental system to distinguish between DOA and DOA plus is needed. In this study, we found that loss-of-function mutations of the dOPA1 gene in Drosophila can imitate the pathology of optic nerve degeneration observed in DOA. We successfully rescued this degeneration by expressing the human OPA1 (hOPA1) gene, indicating that hOPA1 is functionally interchangeable with dOPA1 in the fly system. However, mutations previously identified did not ameliorate the dOPA1 deficiency phenotype. By expressing both WT and DOA plus mutant hOPA1 forms in the optic nerve of dOPA1 mutants, we observed that DOA plus mutations suppressed the rescue, facilitating the distinction between loss-of-function and dominant-negative mutations in hOPA1. This fly model aids in distinguishing DOA from DOA plus and guides initial hOPA1 mutation treatment strategies.
引用
收藏
页数:25
相关论文
共 50 条
  • [31] Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations
    Rocca, Maria A.
    Bianchi-Marzoli, Stefania
    Messina, Roberta
    Cascavilla, Maria Lucia
    Zeviani, Massimo
    Lamperti, Costanza
    Milesi, Jacopo
    Carta, Arturo
    Cammarata, Gabriella
    Leocani, Letizia
    Lamantea, Eleonora
    Bandello, Francesco
    Comi, Giancarlo
    Falini, Andrea
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2015, 262 (05) : 1216 - 1227
  • [32] Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis
    Millet, Aurelie M. C.
    Bertholet, Ambre M.
    Daloyau, Marlene
    Reynier, Pascal
    Galinier, Anne
    Devin, Anne
    Wissinguer, Bernd
    Belenguer, Pascale
    Davezac, Noelie
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (06): : 408 - 421
  • [33] OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
    Yu-Wai-Man, Patrick
    Trenell, Michael I.
    Hollingsworth, Kieren G.
    Griffiths, Philip G.
    Chinnery, Patrick F.
    BRAIN, 2011, 134
  • [34] Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants
    Li, Huajin
    Jones, Evan M.
    Li, Hui
    Yang, Lizhu
    Sun, Zixi
    Yuan, Zhisheng
    Chen, Rui
    Dong, Fangtian
    Sui, Ruifang
    OPHTHALMIC GENETICS, 2018, 39 (05) : 569 - 576
  • [35] Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics
    Alavi, Marcel V.
    Fuhrmann, Nico
    MOLECULAR NEURODEGENERATION, 2013, 8
  • [36] Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy
    de Muijnck, Cansu
    Haer-Wigman, Lonneke
    van Everdingen, Judith A. M.
    Lushchyk, Tanya
    Heutinck, Pam A. T.
    van Dooren, Marieke F.
    Kievit, Anneke J. A.
    Verhoeven, Virginie J. M.
    Simon, Marleen E. H.
    Wasmann, Rosemarie A.
    Notting, Irene C.
    De Baere, Elfride
    Walraedt, Sophie
    De Zaeytijd, Julie
    van den Broeck, Filip
    Leroy, Bart P.
    Boon, Camiel J. F.
    van Genderen, Maria M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells
    Venkatesh, Aditya
    McKenty, Taylor
    Ali, Syed
    Sonntag, Donna
    Ravipaty, Shobha
    Cui, Yanyan
    Slate, Deirdre
    Lin, Qian
    Christiansen, Anne
    Jacobson, Sarah
    Kach, Jacob
    Lim, Kian Huat
    Srinivasan, Vaishnavi
    Zinshteyn, Boris
    Aznarez, Isabel
    Huryn, Laryssa A.
    Li, Zhiyu
    Hufnagel, Robert B.
    Liau, Gene
    Anderson, Karen
    Hoger, Jeff
    NUCLEIC ACID THERAPEUTICS, 2024, 34 (05) : 221 - 233
  • [38] Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families
    Pretegiani, E.
    Rosini, F.
    Rufa, A.
    Gallus, G. N.
    Cardaioli, E.
    Da Pozzo, P.
    Bianchi, S.
    Serchi, V.
    Collura, M.
    Franceschini, R.
    Marzoli, S. Bianchi
    Dotti, M. T.
    Federico, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 382 : 29 - 35
  • [39] Biallelic Optic Atrophy 1 (OPA1) Related Disorder-Case Report and Literature Review
    Al Othman, Bayan
    Ong, Jia Ern
    Dumitrescu, Alina, V
    GENES, 2022, 13 (06)
  • [40] First Cases of Dominant Optic Atrophy in Saudi Arabia: Report of Two Novel OPA1 Mutations
    Galvez-Ruiz, Alberto
    Neuhaus, Christine
    Bergmann, Carsten
    Bolz, Hanno
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2013, 33 (04) : 354 - 358